Professional Documents
Culture Documents
Indication/Mechanis
Generic & Dose, strength & Adverse/side effects Nursing
m of Rationale Client Teaching
Brand Name formulation drug Interaction Responsibility
Action
Ordered:] Indications: Adverse reaction: Assessment:
Generic:
Chronic constipation, Bloating; faintness; -Auscultate bowel sounds -.By checking frequency &
Bisacodyl preparation for nausea; rectal at least once per shift. characteristic of stools. >.Advise patient to swallow
Dulcolax rectal surgery/rectal/bowel irritation; stomach -.Obtain history of bowel enteric-coated tablet whole to
suppository 10 examination fullness, cramps, or disorder, GI status, fluid -Check for pain and cramping avoid GI irritation.
mg adult, 2 discomfort; vomiting. intake, nutritional status, and to know the condition of
Brand: suppositories per Mechanism of action: exercise habits & normal the patient >Advise patient to report
rectum patterns of eliminations. adverse effects to prescriber.
. Bisacodyl works by
dulcolax Timing: stimulating enteric Drug interactions: -Be alert for adverse >Warn patient against excessive
nerves to cause reactions and drug inter use of drugs.
Classification: HS(8pm) colonic mass . May cause gastric action -to establish proper >Teach patient about dietary
movements. It is also irritation or dyspnea precautionary measures and sources of fiber, including bran
Stimulant Duration: a contact laxative; it from premature management for possible and other cereals use of drugs..
laxative increases fluid and dissolution of enteric adverse effects of the drug.
NaCl secretion coating. avoid use -Assess for baseline data >teach patient the proper storage
Other forms:
(lippicott & wilkins together --to indicate baseline data and of the medication.
2009 Ed. ;213) monitor drug’s effectiveness.
Enema: 10mg/30
-To prepare the patient for any
ml
side effect.
Tablet(delayed-
release): 10 mg
Tablets(enteric-
coated
DRUG STUDY
Generic: Ordered: Indications: Adverse/Side Effects: Assessment: *Teach patient to recognize and
immediately report signs and
Ketorolac >Short-term CNS:dizziness, 1. Assess patient’s pain before -To monitor drug’s symptoms of GI bleeding.
Tromethamine management of and after drug therapy. effectiveness.
pain drowsiness, *Advise patient to report
persistent or worsening pain.
headache,
2. Be alert for adverse -To avoid severe adverse *Explain that drug is intended
Timing: insomnia, reactions and drug effects. only for short term use.
interactions.
Mechanism of CV:edema, *Take drug as prescribed by the
Brand: Action: hypertension, Planning & Implementation: physician.
Duration: palpitations
*May inhibit 3. Drug may cause peptic *Tell patient not to exceed to the
6-8 hours prostaglandin EENT:transient ulcers, GI bleeding, or prescribed amount.
synthesis stinging and burning perforation of the stomach and
Available Forms: intestine. -Monitor patient closely.
*Relieves pain GI:diarrhea,
Injection:15 and dyspepsia, GI pain, 4. List all the medication the
Classification: mg/ml,30 mg/ml inflammation nausea patient is taking.
-To prevent drug interaction.
• NSAID Opthalmic GU:hematuria, 5. Apply pressure to injection
• Analgesi Solution:0.4% , polyuria, renal failure site for 15-30 seconds after -To minimize local effects.
cs, anti- 0.5% injection.
inflamm Hematologic:
atory Tablets:10 mg
anemia, eosinophilia,
purpura
Skin:sweating
Other:pain at
injection site.
Drug Interaction:
Drug-Drug. Anti-
hypertensive,
diuretics:May
decrease
effectiveness of these
drugs. Monitor
reactions closely.
Lithium:May increase
lithium level.
Warfarin:May
increase levels of free
salicylates or
warfarin in blood.
Methotrexate:
May decrease
methotrexate
clearance and
increase toxicity.